GCV Asia Congress 2017
Skip Content

6 September 2017

23andMe examines $200m investment

The corporate-backed genetic testing company is targeting a $200m funding round led by Sequoia Capital.

Author: Thierry Heles, Reporter

23andMe, a US-based genetic testing and analysis provider backed by corporates such as conglomerate Alphabet, is set to raise nearly $200m in a series F round led by Sequoia Capital, TechCrunch reported today.